Savara Inc.
SVRA:NASDAQ
Savara is an orphan lung disease company. Savara's strategy involves expanding its pipeline of potentially best-in-class products through indication expansion, strategic development partnerships and product acquisitions, with the goal of becoming a leading company in its field.
Streetwise Company Fact Sheet2026/3/20 21:57:59
(SVRA:NASDAQ)
Analyst coverage
| H.C. Wainwright & Co. — Andrew Fein |
Streetwise Reports Articles
| 03/16/2026 - View Article |
© 2026 Streetwise Reports. All rights reserved.
Streetwise Reports is registered with the U.S. Patent and Trademark Office.
